TANG CAPITAL MANAGEMENT, LLC 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-03 4:15 pm Sale | 2025-08-29 | 13D | iTeos Therapeutics, Inc. ITOS | TANG CAPITAL MANAGEMENT, LLC | 10,000 100.000% | -3,816,692 (-99.74%) | Filing |
| 2025-07-22 4:31 pm Unchanged | 2025-07-18 | 13D | iTeos Therapeutics, Inc. ITOS | TANG CAPITAL MANAGEMENT, LLC | 3,826,692 9.990% | 0 (Unchanged) | Filing |
| 2025-06-12 4:27 pm Unchanged | 2025-06-11 | 13D | iTeos Therapeutics, Inc. ITOS | TANG CAPITAL MANAGEMENT, LLC | 3,826,692 9.990% | 0 (Unchanged) | Filing |
| 2025-05-15 4:15 pm Purchase | 2025-05-13 | 13G | iTeos Therapeutics, Inc. ITOS | TANG CAPITAL MANAGEMENT, LLC | 3,826,692 9.990% | 3,604,976 (+1625.94%) | Filing |
| 2025-02-14 4:00 pm Sale | 2024-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | TANG CAPITAL MANAGEMENT, LLC | 221,716 0.600% | -2,186,084 (-90.79%) | Filing |
| 2024-09-30 09:00 am Purchase | 2024-09-26 | 13G | iTeos Therapeutics, Inc. ITOS | TANG CAPITAL MANAGEMENT, LLC | 2,407,800 6.600% | 2,407,800 (New Position) | Filing |